10.1136/esmoopen-2019-000656.supp1 Supplementary data Effectiveness in patients aged ≥75 years according to ECOG PS There was a clear trend towards improved PFS according to ECOG PS ( figure 2A ).
← all excerpts
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR).
1
—
—